Medacta reports 9.7% revenue growth in first half of 2026

Recent financial reports highlight varying growth rates across different sectors. Netacea achieved a significant 42% revenue increase during the first half of 2026. Medacta also reported positive momentum with a 9.7% revenue growth for the same period. Meanwhile, Purplebricks recorded a 7% rise in revenue, navigating a challenging UK market. These figures demonstrate diverse performance levels among the companies, with Netacea leading in growth percentage while Purplebricks manages volatility within its specific regional economy.